Sort
130,381 grants matching “hiv”
Refinement of DNA-Launched NanoParticles decorated with Apex and CD4bs B cell lineage targeting Envs (DLNP-ACEs)
$1,163,370Daniel Kulp · Wistar Institute · U19 · FY2023 · AI
ALCOHOL, HIV, AND THE BRAIN
$1,163,273Sri International · U01 · FY2005 · AA
Virus biology scientific research support component
$1,163,217Beatrice H Hahn · Duke University · UM1 · FY2012 · AI
The Florida Node Alliance of the National Drug Abuse Treatment Clinical Trials Network
$1,163,175Jose Szapocznik · University Of Miami School Of Medicine · UG1 · FY2019 · DA
Elucidating the Regulation of HIV RNA Functions:Translation and Genome Packaging
$1,162,916Wei-Shau Hu · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Defining Mechanisms of HIV-1 Gag:RNA Interactions and Virus Assembly
$1,162,916Wei-Shau Hu · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Reproductive Toxicology Studies of Elsulfavirin with Toxicokinetics in Rats, and to Support the Development of Mitochondrial Toxicity Assays and Sample Analysis for Mitochondrial Toxicity Assessment
$1,162,805Jon Mirsalis · Sri International · N01 · FY2019 · AI
Effects of Medication for Opioid Use Disorder on Microglial Activation and Neurocognition in People Living with HIV
$1,162,746Shelli Farhadian · Yale University · R01 · FY2025 · DA
Early Antiretroviral Therapy and HIV Remission in Perinatal Infection
$1,162,650Deborah Persaud · Johns Hopkins University · R01 · FY2018 · HD
Clinical Trials Network Mid-Atlantic Collaborative Group
$1,162,492Maxine L Stitzer · Johns Hopkins University · U10 · FY2010 · DA
Pediatric Clinical Trials Program for AIDS
$1,162,490Baylor College Of Medicine · U01 · FY2004 · AI
HIV/AIDS Vaccine Development
$1,162,466Gary J Nabel · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Novel approaches to monitoring and utilizing adherence to HIV therapy in Africa
$1,162,415David Roy Bangsberg · Massachusetts General Hospital · R01 · FY2012 · MH
Origin and maturation of protective memory B cell responses against pathogenic viruses in natural infections and upon vaccination.
$1,162,204Mattia Bonsignori · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Core A: Administrative Core
$1,162,188Paul A Volberding · University Of California, San Francisco · P30 · FY2020 · AI
Production of Pedigreed SPF Rhesus Macaques
$1,162,130Jeffrey A Roberts · University Of California At Davis · U42 · FY2021 · OD
A preclinical large animal model for globin gene transfer
$1,162,073John Tisdale · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL
TRIAD-2 Center for Health Disparities Research
$1,162,010Debra C Wallace · University Of North Carolina Greensboro · P20 · FY2015 · MD
San Diego EXPORT Comprehensive NCMHD Research Center
$1,162,008Sandra P Daley · University Of California, San Diego · P60 · FY2007 · MD
IMPLEMENTATION AND EVALUATION OF ENHANCED HIV PREVENTION PLANNING IN DALLAS COUNT
$1,161,989Janna Zumbrun · Texas State Dept Of Health Services · U65 · FY2011 · PS
Host Defense Regulation and Viral Oncogenesis
$1,161,984Glen N. Barber · University Of Miami School Of Medicine · P01 · FY2009 · CA
HIV-1 Q23.17 Env: Engineering a novel immunogen to elicit broadly neutralizing antibodies
$1,161,799George M Shaw · University Of Pennsylvania · R01 · FY2023 · AI
Using MOST to optimize an HIV care continuum intervention for vulnerable populations
$1,161,504Marya Gwadz · New York University · R01 · FY2016 · DA
The Impact of HIV Infection on Immunologic, Transcriptomic, and Metabolomic Signatures of Medication-Assisted Therapy for Opioid Addiction
$1,161,477Sandra Ann Springer · Yale University · R01 · FY2016 · DA
Molecular Biology: Viral Glial Gene Interaction in Brain
$1,160,961Kamel Khalili · Temple Univ Of The Commonwealth · P01 · FY2007 · NS